Medicare has long-been prohibited by law from covering medications used specifically for weight loss but covers GLP-1 drugs for other approved conditions like type 2 diabetes
Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis
Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry
Am I a candidate for GLP-1 medications
Is It Necessary? Current Opinion in Clinical Nutrition and Metabolic Care, vol
Contraindications Tirzepatide, whether compounded or brand-name, should not be used by individuals with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, severe gastroparesis or gastrointestinal disease, or during pregnancy